From: Unrecognized diabetes in critically ill COVID-19 patients
Characteristic | Total (N = 44) | HbA1c < 5.7% (N = 4) | HbA1c ≥ 5.7 < 6.5% (N = 16) | HbA1c ≥ 6.5% (N = 24) |
---|---|---|---|---|
Age—median (IQR) [years] | 61.5 (53.0–68.0) | 53.5 (43.8–64.0) | 64 (53.8–68.0) | 59 (53.8–69.8) |
Male sex—no. (%) | 32 (72) | 3 (75) | 13 (81) | 16 (66) |
Caucasian race—no. (%) | 32 (72) | 3 (75) | 13 (81) | 16 (66) |
BMI—median (IQR) [kg/m2] | 29.4 (26.2–32.7) | 27.8 (24.9–30.6) | 27.7 (25.5–34.8) | 29.5 (26.9–32.6) |
HbA1c—median (IQR) [%] | 6.5 (6.1–6.7) | 5.6 (5.5–5.6) | 6.2 (5.9–6.3) | 6.7 (6.6–7.1) |
Maximum CRP—median (IQR) [mg/dl] | 31.5 [20.5–35.5] | 18.3 [16.9–20.9] | 29.8 [19.7–35.9] | 33.0 [22.4–35.8] |
Maximum IL-6—median (IQR) [ng/l] | 797.9 [381.7–1886.3] | 284.9 [212.2–383.2] | 1097.4 [403.8–2200.3] | 851.9 [419.3–2156.3] |
Known comorbidity*—no. (%) | ||||
 Metabolic syndrome | 8 (18) | 0 (0.0) | 4 (25) | 4 (17) |
 Prediabetes | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
 Diabetes mellitus type I | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
 Diabetes mellitus type II | 7 (15) | 1 (25) | 0 (0) | 6 (25) |
 Cardiovascular | 11 (25) | 2 (50) | 2 (13) | 7 (29) |
 Hypertension | 19 (43) | 2 (50) | 7 (44) | 10 (42) |
 Renal | 6 (13) | 0 (0) | 3 (19) | 3 (13) |
 Liver | 4 (9) | 0 (0) | 2 (13) | 2 (8) |
 Metastatic disease | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
 Hematological malignancy | 2 (4) | 0 (0) | 2 (13) | 0 (0) |
 Non-hematological malignancy | 3 (7) | 1 (25) | 2 (13) | 0 (0) |
 Immunosuppression | 5 (11) | 0 (0) | 3 (19) | 2 (8) |
 COPD | 6 (13) | 0 (0) | 2 (13) | 4 (17) |
 Asthma | 4 (9) | 1 (25) | 2 (13) | 1 (4) |
 Respiratory disease—others | 4 (9) | 1 (25) | 3 (19) | 0 (0) |
 Neurologic comorbidity | 3 (7) | 1 (25) | 2 (13) | 0 (0) |
Chest radiographic findings consistent with viral pneumonia—no. (%) | 43 (98) | 4 (100) | 16 (100) | 23 (96) |
SARS-CoV-2-PCR positive—no. (%) | 44 (100) | 4 (100) | 16 (100) | 24 (100) |
Invasive mechanical ventilation—no. (%) | 35 (80) | 2 (50) | 13 (81) | 20 (84) |
Veno-venous extracorporeal membrane oxygenation—no. (%) | 4 (9) | 1 (25) | 1 (6) | 2 (8) |
Death in hospital—no. (%) | 11 (25) | 0 (0) | 4 (25) | 7 (29) |